A gene associated with both protection against bacterial infection and excessive blood clotting could offer new insights into treatment strategies for deep-vein thrombosis - the formation of a harmful clot in a deep vein. The gene produces an enzyme that, if inhibited via a specific drug...
A compound that mops up debris of damaged cells from the bloodstream may be the first in a new class of drugs designed to address one of medicine's most difficult challenges - stopping the formation of blood clots without triggering equally threatening bleeding...
More...
A history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota...
A new study provides welcome news for patients with a common clotting disorder known as venous thromboembolism (VTE). The condition is estimated to impact 62,000 Canadians and half-a-million Americans every year, and occurs when an abnormal clot forms in a vein and restricts the flow of blood...